These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36382308)

  • 1. Roles of effective stabilizers in improving oral bioavailability of naringenin nanocrystals: Maintenance of supersaturation generated upon dissolution by inhibition of drug dimerization.
    Zhang G; Guan H; Li J; Li M; Sui X; Tian B; Dong H; Liu B; He Z; Li N; Zhao M; Fu Q
    Asian J Pharm Sci; 2022 Aug; 17(5):741-750. PubMed ID: 36382308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers.
    Mu S; Li M; Guo M; Yang W; Wang Y; Li J; Fu Q; He Z
    Colloids Surf B Biointerfaces; 2016 Nov; 147():73-80. PubMed ID: 27490456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilizer-induced different in vivo behaviors for intramuscularly long-acting celecoxib nanocrystals.
    Qin M; Xin J; Han W; Li M; Sui X; Dong H; Fu Q; He Z
    Int J Pharm; 2022 Nov; 628():122298. PubMed ID: 36257466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving stability and oral bioavailability of hydroxycamptothecin via nanocrystals in microparticles (NCs/MPs) technology.
    Wang Y; Xuan J; Zhao G; Wang D; Ying N; Zhuang J
    Int J Pharm; 2021 Jul; 604():120729. PubMed ID: 34029666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
    Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
    Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs-The Case of Alpha-Mangostin.
    Budiman A; Citraloka ZG; Muchtaridi M; Sriwidodo S; Aulifa DL; Rusdin A
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide.
    Ma Y; Yang Y; Xie J; Xu J; Yue P; Yang M
    Int J Nanomedicine; 2018; 13():3763-3779. PubMed ID: 29988798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
    Qian F; Wang J; Hartley R; Tao J; Haddadin R; Mathias N; Hussain M
    Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin nanocrystals for improving anti-rheumatoid arthritis activity.
    Zhang G; Sun G; Guan H; Li M; Liu Y; Tian B; He Z; Fu Q
    Asian J Pharm Sci; 2021 Nov; 16(6):816-825. PubMed ID: 35027956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of nimodipine nanocrystals for oral administration.
    Li J; Fu Q; Liu X; Li M; Wang Y
    Arch Pharm Res; 2016 Feb; 39(2):202-212. PubMed ID: 26584914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
    Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
    Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways.
    Zhu Y; Fu Y; Zhang A; Wang X; Zhao Z; Zhang Y; Yin T; Gou J; Wang Y; He H; Tang X
    Eur J Pharm Sci; 2022 Jan; 168():106047. PubMed ID: 34687899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
    Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
    Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Promising Role of Chitosan-Poloxamer 188 Nanocrystals in Improving Diosmin Dissolution and Therapeutic Efficacy against Ferrous Sulfate-Induced Hepatic Injury in Rats.
    Lotfy NS; Borg TM; Mohamed EA
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A carbohydrate polymer is a critical variable in the formulation of drug nanocrystals: a case study of idebenone.
    Ma M; Zhang G; Li W; Li M; Fu Q; He Z
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1403-1411. PubMed ID: 31622561
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
    Peng R; Huang J; He L; Zhao L; Wang C; Wei W; Xia T; Mao Y; Wen Y; Wang L; Yang J
    Eur J Pharm Sci; 2020 Apr; 146():105262. PubMed ID: 32060005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm.
    Zhang X; Wang A; Yang X; Wang Y; Wang Q; Hu R; Anwaier G; Di C; Qi R; Huang Y
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1109-1119. PubMed ID: 34491473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of particle shapes on the oral delivery of drug nanocrystals: Mucus permeation, transepithelial transport and bioavailability.
    Guo M; Wei M; Li W; Guo M; Guo C; Ma M; Wang Y; Yang Z; Li M; Fu Q; Yang L; He Z
    J Control Release; 2019 Aug; 307():64-75. PubMed ID: 31207275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.